SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017255
Filing Date
2019-05-08
Accepted
2019-05-08 16:34:14
Documents
59
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sgmo-10q_20190331.htm 10-Q 1940145
2 EX-10.3 sgmo-ex103_230.htm EX-10.3 32869
3 EX-31.1 sgmo-ex311_6.htm EX-31.1 15835
4 EX-31.2 sgmo-ex312_7.htm EX-31.2 15920
5 EX-32.1 sgmo-ex321_8.htm EX-32.1 7803
  Complete submission text file 0001564590-19-017255.txt   7532272

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sgmo-20190331.xml EX-101.INS 1740779
7 XBRL TAXONOMY EXTENSION SCHEMA sgmo-20190331.xsd EX-101.SCH 54884
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sgmo-20190331_cal.xml EX-101.CAL 61927
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sgmo-20190331_def.xml EX-101.DEF 213362
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgmo-20190331_lab.xml EX-101.LAB 411708
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgmo-20190331_pre.xml EX-101.PRE 317910
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 19807162
SIC: 2836 Biological Products, (No Diagnostic Substances)